全文获取类型
收费全文 | 6159篇 |
免费 | 681篇 |
国内免费 | 49篇 |
专业分类
耳鼻咽喉 | 54篇 |
儿科学 | 205篇 |
妇产科学 | 73篇 |
基础医学 | 593篇 |
口腔科学 | 179篇 |
临床医学 | 680篇 |
内科学 | 1768篇 |
皮肤病学 | 88篇 |
神经病学 | 617篇 |
特种医学 | 465篇 |
外科学 | 917篇 |
综合类 | 100篇 |
一般理论 | 1篇 |
预防医学 | 306篇 |
眼科学 | 118篇 |
药学 | 320篇 |
中国医学 | 5篇 |
肿瘤学 | 400篇 |
出版年
2023年 | 75篇 |
2021年 | 78篇 |
2020年 | 125篇 |
2019年 | 57篇 |
2018年 | 152篇 |
2017年 | 134篇 |
2016年 | 128篇 |
2015年 | 115篇 |
2014年 | 196篇 |
2013年 | 239篇 |
2012年 | 212篇 |
2011年 | 228篇 |
2010年 | 164篇 |
2009年 | 214篇 |
2008年 | 246篇 |
2007年 | 219篇 |
2006年 | 207篇 |
2005年 | 191篇 |
2004年 | 154篇 |
2003年 | 156篇 |
2002年 | 152篇 |
2001年 | 207篇 |
2000年 | 183篇 |
1999年 | 173篇 |
1998年 | 139篇 |
1997年 | 139篇 |
1996年 | 117篇 |
1995年 | 104篇 |
1994年 | 81篇 |
1993年 | 84篇 |
1992年 | 162篇 |
1991年 | 147篇 |
1990年 | 155篇 |
1989年 | 188篇 |
1988年 | 165篇 |
1987年 | 132篇 |
1986年 | 123篇 |
1985年 | 107篇 |
1984年 | 69篇 |
1983年 | 54篇 |
1982年 | 54篇 |
1981年 | 59篇 |
1980年 | 50篇 |
1979年 | 70篇 |
1978年 | 64篇 |
1977年 | 45篇 |
1976年 | 50篇 |
1973年 | 51篇 |
1972年 | 44篇 |
1970年 | 43篇 |
排序方式: 共有6889条查询结果,搜索用时 15 毫秒
71.
W Günther U Klages M Mayr C Haag N Müller I Hantschk P Streck R Steinberg T Baghai J.P. Banquet P Rondot 《Clinical neurophysiology》1993,23(6)
Twenty-six untreated schizophrenic inpatients and 34 control persons were investigated using 16-channel EEG mapping during resting, manumotor and music perception tasks. Power values of activation tasks were each referenced to a separate, immediately preceding resting condition, using conventional delta, theta, alpha and 2 beta frequency bands. Results in delta and alpha bands, which maximally separated the two groups, are reported only for space reasons. Results indicated a “nonreactivity” (in all frequency bands) on the two activation paradigms in schizophrenic patients as a group. Major gender effects were obtained in normal persons, but not signs of nonreactivity comparable to patients. Subdividing patients exclusively by means of their EEG changes on activation produced meaningful clinical subgroups of “positive/negative” schizophrenics. This latter finding could contribute towards clinical utility of EEG mapping in psychiatry.
Résumé
Vingt-six malades schizophrènes non traités par des médicaments étaient étudiés par l'EEG topographique à 16 voies pendant des tâches psychomotrices et de la perception musicale. Ils étaient comparés à 34 personnes contrôles. Les valeurs de la puissance étaient calculées dans les états de repos et d'activation dans les bandes de fréquences (conventionnelles) delta, theta, alpha et bêta 1 et 2. Seules les bandes delta et alpha, qui séparaient au maximum les deux groupes, sont montrées dans l'article en raison de l'espace. Tandis que les sujets normaux montraient des changements majeurs de l'EEG pendant les deux types de tâches — modifié par le sexe, les malades schizophrènes montraient au contraire des signes de « non-réactivité . L'essai de grouper les malades exclusivement par leurs changements de l'EEG pendant l'activation cérébrale qu'effectuait un groupe était cliniquement significative, en séparant les malades portant des symptomes « positivesde ceux avec des symptomes « négatives . Le résultat final pourrait indiquer une valeur clinique de l'EEG quantifié pour la psychiatrie. 相似文献72.
Osteonecrosis of the femoral head in the adult is a progressive condition that, if untreated, usually results in femoral head collapse and secondary osteoarthritis. The experimental application of electrical and electromagnetic fields has been shown to favorably affect a number of biological processes pertinent to osteonecrosis of the femoral head and has led to several clinical trials. The condition has been treated by the application of electrical fields invasively by the surgical implantation of electrodes within the femoral head and noninvasively by capacitative or inductive coupling. This review describes results in osteonecrosis of the femoral head with these therapeutic techniques. Stimulation by means of inductive coupling with pulsed magnetic fields seems to be the most promising technique studied so far, but the optimal signal characteristics and device design are not yet known. 相似文献
73.
Stoodley MA Thompson RC Mitchell RS Marks MP Steinberg GK 《Neurosurgery》2000,46(4):841-51; discussion 851-2
74.
75.
Yves Claustre Danielle De Peretti Philippe Brun Christiane Gueudet Nathalie Allouard Richard Alonso Jo?lle Lourdelet André Oblin Gabrielle Damoiseau Dominique Fran?on Marie-Fran?oise Suaud-Chagny Régis Steinberg Mireille Sevrin Hans Schoemaker Pascal George Philippe Soubrié Bernard Scatton 《Neuropsychopharmacology》2003,28(12):2064-2076
SSR181507 ((3-exo)-8-benzoyl-N-[[(2S)7-chloro-2,3-dihydro-1,4-benzodioxin-1-yl]methyl]-8-azabicyclo[3.2.1]octane-3-methanamine monohydrochloride) is a novel tropanemethanamine benzodioxane derivative that possesses high and selective affinities for D2-like and 5-HT(1A) receptors (K(I)=0.8, 0.2, and 0.2 nM for human D(2), D(3), and 5-HT(1A), respectively). In vivo, SSR181507 inhibited [(3)H]raclopride binding to D(2) receptors in the rat (ID(50)=0.9 and 1 mg/kg, i.p. in limbic system and striatum, respectively). It displayed D(2) antagonist and 5-HT(1A) agonist properties in the same concentration range in vitro (IC(50)=5.3 nM and EC(50)=2.3 nM, respectively, in the GTPgammaS model) and in the same dose range in vivo (ED(50)=1.6 and 0.7 mg/kg, i.p. on striatal DA and 5-HT synthesis, respectively, and 0.03-0.3 mg/kg, i.v. on dorsal raphe nucleus firing rate). It selectively enhanced Fos immunoreactivity in mesocorticolimbic areas as compared to the striatum. This regional selectivity was confirmed in electrophysiological studies where SSR181507, given acutely (0.1-3 mg/kg, i.p.) or chronically (3 mg/kg, i.p., o.d., 22 days), increased or decreased, respectively, the number of spontaneous active DA cells in the ventral tegmental area, but not in the substantia nigra. Moreover, SSR181507 increased both basal and phasic DA efflux (as assessed by microdialysis and electrochemistry) in the medial prefrontal cortex and nucleus accumbens, but not in the striatum. This study shows that the combination of D(2) receptor antagonism and 5-HT(1A) agonism, in the same dose range, confers on SSR181507 a unique neurochemical and electrophysiological profile and suggests the potential of this compound for the treatment of the main dimensions of schizophrenia. 相似文献
76.
Long-term follow-up for locally advanced and inflammatory breast cancer patients treated with multimodality therapy. 总被引:4,自引:0,他引:4
Jennifer A Low Arlene W Berman Seth M Steinberg David N Danforth Marc E Lippman Sandra M Swain 《Journal of clinical oncology》2004,22(20):4067-4074
PURPOSE: To determine long-term event-free (EFS) and overall survival (OS) for patients with stage III breast cancer treated with combined-modality therapy. PATIENTS AND METHODS: Between 1980 and 1988, 107 patients with stage III breast cancer were prospectively enrolled for study at the National Cancer Institute and stratified by whether or not they had features of inflammatory breast cancer (IBC). Patients were treated to best response with cyclophosphamide, doxorubicin, methotrexate, fluorouracil, leucovorin, and hormonal synchronization with conjugated estrogens and tamoxifen. Patients with pathologic complete response received definitive radiotherapy to the breast and axilla, whereas patients with residual disease underwent mastectomy, lymph node dissection, and radiotherapy. All patients underwent six additional cycles of adjuvant chemotherapy. RESULTS: OS and EFS were obtained with a median live patient follow-up time of 16.8 years. The 46 IBC patients had a median OS of 3.8 years and EFS of 2.3 years, compared with 12.2 and 9.0 years, respectively, in stage IIIA breast cancer patients. Fifteen-year OS survival was 20% for IBC versus 50% for stage IIIA patients and 23% for stage IIIB non-IBC. Pathologic response was not associated with improved survival for stage IIIA or IBC patients. Presence of dermal lymphatic invasion did not change the probability of survival in clinical IBC patients. CONCLUSION: Fifteen-year follow-up of stage IIIA and inflammatory breast cancer is rarely reported; IBC patients have a poor long-term outlook. 相似文献
77.
78.
Antoinette R Tan Xiaowei Yang Stephen M Hewitt Arlene Berman Erin R Lepper Alex Sparreboom Allyson L Parr William D Figg Catherine Chow Seth M Steinberg Stephen L Bacharach Millie Whatley Jorge A Carrasquillo Jaime S Brahim Seth A Ettenberg Stan Lipkowitz Sandra M Swain 《Journal of clinical oncology》2004,22(15):3080-3090
PURPOSE: To evaluate changes in epidermal growth factor receptor (EGFR) phosphorylation and its downstream signaling in tumor and surrogate tissue biopsies in patients with metastatic breast cancer treated with erlotinib, an EGFR tyrosine kinase inhibitor, and to assess relationships between biomarkers in tumor and normal tissues and between biomarkers and pharmacokinetics. PATIENTS AND METHODS: Eighteen patients were treated orally with 150 mg/d of erlotinib. Ki67, EGFR, phosphorylated EGFR (pEGFR), phosphorylated mitogen-activated protein kinase (pMAPK), and phosphorylated AKT (pAKT) in 15 paired tumor, skin, and buccal mucosa biopsies (at baseline and after 1 month of therapy) were examined by immunohistochemistry and analyzed quantitatively. Pharmacokinetic sampling was also obtained. RESULTS: The stratum corneum layer and Ki67 in keratinocytes of the epidermis in 15 paired skin biopsies significantly decreased after treatment (P = .0005 and P = .0003, respectively). No significant change in Ki67 was detected in 15 tumors, and no responses were observed. One was EGFR-positive and displayed heterogeneous expression of the receptor, and 14 were EGFR-negative. In the EGFR-positive tumor, pEGFR, pMAPK, and pAKT were reduced after treatment. Paradoxically, pEGFR was increased in EGFR-negative tumors post-treatment (P = .001). Although markers were reduced in surrogate and tumor tissues in the patient with EGFR-positive tumor, no apparent associations were observed in patients with EGFR-negative tumor. CONCLUSION: Erlotinib has inhibitory biologic effects on normal surrogate tissues and on an EGFR-positive tumor. The lack of reduced tumor proliferation may be attributed to the heterogeneous expression of receptor in the EGFR-positive patient and absence of target in this cohort of heavily pretreated patients. 相似文献
79.
80.
GA Smith SD Strausbaugh C Harbeck-Weber DM Cohen BJ Shields JD Powers 《Pediatrics》1997,100(5):825-830
OBJECTIVE: To compare the effectiveness of three new topical anesthetics that do not contain cocaine (prilocaine-phenylephrine, tetracaine-phenylephrine [tetraphen], and tetracaine-lidocaine-phenylephrine) to that of tetracaine-adrenaline-cocaine (TAC) during laceration repair in children. DESIGN: Prospective, randomized, double-blind clinical trial. SETTING: The emergency department of an urban children's hospital. PARTICIPANTS: Children 1 year of age or older with a laceration = 5 cm in length that required suturing. Intervention. A total of 240 children were randomly assigned to one of four treatment groups. OUTCOME MEASURES: Pain felt during suturing was scored by suture technicians, research assistants, parents, and patients >/= 5 years of age using a visual analogue scale (VAS). Suture technicians, research assistants, and parents also scored pain using a seven-point Likert scale. In addition, suture technicians completed an anesthetic effectiveness scale. RESULTS: There was consistently no difference demonstrated between the effectiveness of tetraphen and that of TAC for each outcome measure of each observer group. A statistically significant difference was seen among anesthetics when comparing VAS and Likert scale scores of suture technicians and Likert scale scores of research assistants. Based on post hoc analyses, these statistically significant differences were between TAC and prilocaine-phenylephrine (suture technician VAS and Likert scale) and between TAC and tetracaine-lidocaine-phenyl-ephrine (suture technician Likert scale), but not between TAC and tetraphen. When power analyses were performed using alpha = 0.05 and beta = 0.20, it was possible to detect a difference of 1.2 VAS units for each of the observer groups. Based on anesthetic effectiveness scale scores, the three new topical preparations collectively performed significantly better on the face and scalp than on the extremities (relative risk = 1.83; 95% confidence interval 1.20 < relative risk < 2.79). CONCLUSION: This study demonstrated the effectiveness and safety of three new non-cocaine-containing topical anesthetics. Consistently, there was no statistical difference demonstrated between the effectiveness of tetraphen and that of TAC for each outcome measure of each observer group. Tetraphen offers an effective alternative to TAC during laceration repair in children. 相似文献